Taishin Pharmaceutical Co., Ltd. Announces Q1 2026 EPS of -0.10 Yuan
NQ Score
0/100
N1 Content Completeness
0.5
AI Summary (NQ-processed)
Taishin Pharmaceutical Co., Ltd. (stock code: 6838) reported its Q1 2026 financial results, with an EPS of -0.10 Yuan, revenue of 45 million Yuan, and a net profit of -15 million Yuan, indicating financial challenges.